Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXS-07 in acute migraine
NCT04163185Phase 3Completed
- Sponsor
- Axsome Therapeutics, Inc.
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing AXS-07 with Placebo (2 arms). Primary endpoints: Headache Pain Freedom at 2 hours and Absence of Most Bothersome Symptom at 2 hours. Started Oct 2019; status: completed.
02
Drugs
meloxicam + rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04163185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04163185.